The multi-product oncology deal includes assets that have validated targets and aim to address efficacy and/or tolerability limitations of existing therapies. Read More >>
Firefly Bio’s capabilities in emerging modalities, including the Firelink DAC platform, complement Johnson & Johnson’s existing expertise in antibody engineering.
The companies will use Orionis’s Allo-Glue platform, together with its AI-driven discovery engine, to accelerate target and ligase profiling and molecular glue optimization.
Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Adare’s specialized technology platforms provide taste masking, customized release, multiparticulate systems, and patient-centric dosing solutions. With a proven history in drug delivery, Adare’s facilities in the US and Europe have developed and manufactured more than sixty-five products sold by customers worldwide.
Sino Biological is a leading global CRO with 18+ years’ expertise in protein production and antibody development. Our proprietary recombinant production platforms enable efficient HTP expression to kg-scale manufacturing. We offer integrated services from antibody discovery to engineering and production, accelerating your path from bench to clinic.
